PEAK6
BNTX icon

PEAK6’s BioNTech BNTX Stock Holding History

PEAK6’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.3K Sell
100
-79,700
-100% -$7.5M ﹤0.01% 2554
2026
Q1 		$7.09M Buy
79,800
+200
+0.3% +$20.6K 0.02% 730
2025
Q4 		$7.58M Buy
+79,600
New +$8.02M 0.01% 767
2025
Q2 		– Sell
-5,000
Closed -$455K – 3001
2025
Q1 		$455K Sell
5,000
-74,100
-94% -$8.3M ﹤0.01% 2118
2024
Q4 		$9.01M Buy
+79,100
New +$9.03M 0.02% 616

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

PEAK6's BNTX Position: Q2 2026 in Review

PEAK6 reduced its BioNTech (BNTX) stake by 68% in Q2 2026, selling an estimated $2.77M and leaving 13,584 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

PEAK6 first reported a position in BNTX in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.83M in Q1 2026. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • PEAK6 held 13,584 shares of BioNTech worth $1.26M as of Q2 2026.
  • PEAK6 sold 29,470 BioNTech shares in Q2 2026, an estimated $2.77M.
  • BioNTech made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #1574 holding.
  • PEAK6 first reported a position in BioNTech in Q4 2024 and has held it in 5 quarters since.
  • PEAK6's BioNTech position peaked at $3.83M in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.